Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PFSI
|
Mfn Partners, LP
Director |
BUY
Open market or private purchase
|
Direct | 68,978 Added 5.09% |
$4,303,537
$62.39 p/Share
|
Mar 25
2021 |
|
FTCV
|
Daniel S Loeb
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 85,546 Added 2.77% |
$982,068
$11.48 p/Share
|
Mar 25
2021 |
|
PFSI
|
Farhad Nanji
Director |
BUY
Open market or private purchase
|
Indirect | 68,978 Added 5.09% |
$4,303,537
$62.39 p/Share
|
Mar 25
2021 |
|
VRE
|
A. Akiva Katz |
BUY
Open market or private purchase
|
Indirect | 345,963 Added 9.45% |
$5,369,346
$15.52 p/Share
|
Mar 25
2021 |
|
INFU
|
Paul Andrew Gendron
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 10.71% |
$61,020
$20.34 p/Share
|
Mar 25
2021 |
|
WMPN
|
Glenn Davis |
BUY
Open market or private purchase
|
Indirect | 21,285 Added 27.85% |
$248,396
$11.67 p/Share
|
Mar 25
2021 |
|
EPZM
|
David M Mott
Director |
BUY
Open market or private purchase
|
Direct | 28,231 Added 19.52% |
$225,283
$7.98 p/Share
|
Mar 25
2021 |
|
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.41% |
$8,965
$17.93 p/Share
|
Mar 25
2021 |
|
TURN
|
Kevin Rendino
Chairman and CEO |
BUY
Open market or private purchase
|
Direct | 1,892 Added 0.5% |
$13,887
$7.34 p/Share
|
Mar 25
2021 |
|
VRCA
|
Paul B Manning |
BUY
Open market or private purchase
|
Indirect | 739,830 Added 50.0% |
$10,912,492
$14.75 p/Share
|
Mar 25
2021 |
|
GTIM
|
Charles E Jobson |
BUY
Open market or private purchase
|
Indirect | 16,757 Added 4.93% |
$67,028
$4.0 p/Share
|
Mar 25
2021 |
|
IMAC
|
Michael D Pruitt
Director |
BUY
Open market or private purchase
|
Direct | 750 Added 5.17% |
$1,230
$1.64 p/Share
|
Mar 25
2021 |
|
LBSR
|
Brett Gross
Director |
BUY
Open market or private purchase
|
Direct | 49,412 Added 50.0% |
$54,847
$1.11 p/Share
|
Mar 25
2021 |
|
BIGZ
|
William Stuart Broadbent |
BUY
Open market or private purchase
|
Direct | 9,890 Added 50.0% |
$197,800
$20.0 p/Share
|
Mar 25
2021 |
|
BIGZ
|
Robert W Fairbairn
Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 50.0% |
$400,000
$20.0 p/Share
|
Mar 25
2021 |
|
CMPI
|
Arthur M Krieg
Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct | 10,036 Added 1.33% |
$123,945
$12.35 p/Share
|
Mar 25
2021 |
|
DOCN
|
Access Industries Holdings LLC |
BUY
Open market or private purchase
|
Indirect | 2,127,659 Added 7.6% |
$99,999,973
$47.0 p/Share
|
Mar 25
2021 |
|
ESTC
|
Chetan Puttagunta
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 18.22% |
$110,660
$110.66 p/Share
|
Mar 25
2021 |
|
IMH
|
Rhp Trust, Dated May 31, 2011
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 45,867 Added 1.36% |
$91,275
$1.99 p/Share
|
Mar 25
2021 |
|
IMH
|
Richard H. Pickup
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 45,867 Added 1.36% |
$91,275
$1.99 p/Share
|
Mar 25
2021 |
|
DSE
|
Css LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 11,887 Added 2.47% |
$83,566
$7.03 p/Share
|
Mar 25
2021 |
|
TELA
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.32% |
$65,550
$13.11 p/Share
|
Mar 25
2021 |
|
JAKK
|
Lawrence I Rosen
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 16,200 Added 2.15% |
$124,254
$7.67 p/Share
|
Mar 25
2021 |
|
JAKK
|
Lawrence I Rosen
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 13,843 Added 1.88% |
$110,328
$7.97 p/Share
|
Mar 24
2021 |
|
AIV
|
Terry Considine
Director |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 14.29% |
$582,000
$5.82 p/Share
|
Mar 24
2021 |
|
FRAF
|
Mark R Hollar
EVP, CFO |
BUY
Open market or private purchase
|
Direct | 3 Added 0.05% |
$92
$30.6 p/Share
|
Mar 24
2021 |
|
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.42% |
$8,750
$17.5 p/Share
|
Mar 24
2021 |
|
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 1.28% |
$1,308
$8.72 p/Share
|
Mar 24
2021 |
|
ADVM
|
Laurent Fischer
CEO, PRESIDENT AND DIRECTOR |
BUY
Open market or private purchase
|
Direct | 10,000 Added 27.55% |
$98,800
$9.88 p/Share
|
Mar 24
2021 |
|
ADVM
|
Patrick Machado |
BUY
Open market or private purchase
|
Direct | 10,000 Added 10.19% |
$99,200
$9.92 p/Share
|
Mar 24
2021 |
|
CRTX
|
David Lamond |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 2.64% |
$1,688,500
$33.77 p/Share
|
Mar 24
2021 |
|
JMP
|
Wedbush Securities Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 785 Added 0.04% |
$4,788
$6.1 p/Share
|
Mar 24
2021 |
|
JMP
|
Wedbush Securities Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 785 Added 0.04% |
$4,788
$6.1 p/Share
|
Mar 24
2021 |
|
PFSI
|
Mfn Partners, LP
Director |
BUY
Open market or private purchase
|
Direct | 80,461 Added 6.2% |
$5,016,743
$62.35 p/Share
|
Mar 24
2021 |
|
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 5,239 Added 0.34% |
$62,449
$11.92 p/Share
|
Mar 24
2021 |
|
PFSI
|
Farhad Nanji
Director |
BUY
Open market or private purchase
|
Indirect | 80,461 Added 6.2% |
$5,016,743
$62.35 p/Share
|
Mar 24
2021 |
|
MACK
|
Gary L Crocker |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 14.82% |
$31,700
$6.34 p/Share
|
Mar 24
2021 |
|
PRTA
|
Eco R1 Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 875,000 Added 7.35% |
$18,156,250
$20.75 p/Share
|
Mar 24
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 29 Added 0.18% |
$43,170
$1488.61 p/Share
|
Mar 24
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.25% |
$4,459
$1486.4 p/Share
|
Mar 24
2021 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.19% |
$1,796
$2.66 p/Share
|
Mar 24
2021 |
|
RYI
|
Kevin D Richardson
President, South-East Region |
BUY
Open market or private sale
|
Direct | 7,500 Added 5.03% |
$124,125
$16.55 p/Share
|
Mar 24
2021 |
|
TNXP
|
Seth Lederman
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 16,733 Added 11.03% |
$22,088
$1.32 p/Share
|
Mar 24
2021 |
|
SWBI
|
Mark Peter Smith |
BUY
Open market or private purchase
|
Direct | 1,500 Added 0.99% |
$25,500
$17.0 p/Share
|
Mar 24
2021 |
|
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 3,750 Added 0.08% |
$52,950
$14.12 p/Share
|
Mar 24
2021 |
|
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 3,750 Added 0.08% |
$52,950
$14.12 p/Share
|
Mar 24
2021 |
|
EDSA
|
Michael J Brooks
President |
BUY
Open market or private purchase
|
Direct | 4,500 Added 31.6% |
$22,860
$5.08 p/Share
|
Mar 24
2021 |
|
EDSA
|
Pardeep Nijhawan
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 5,000 Added 0.91% |
$25,800
$5.16 p/Share
|
Mar 24
2021 |
|
CET
|
Simms C Browning
Director |
BUY
Open market or private purchase
|
Direct | 417 Added 2.12% |
$15,533
$37.25 p/Share
|
Mar 24
2021 |
|
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$29,680
$14.84 p/Share
|
Mar 24
2021 |